The Syndromic Multiplex Diagnostic market is a subset of the Diagnostics industry that focuses on the development and commercialization of multiplex assays. These assays are used to detect multiple biomarkers from a single sample, allowing for the simultaneous diagnosis of multiple diseases or conditions. Multiplex assays are used in a variety of clinical settings, including infectious disease, oncology, and autoimmune disease. The Syndromic Multiplex Diagnostic market is driven by the increasing demand for rapid and accurate diagnosis of multiple diseases. This demand is driven by the need for improved patient outcomes, cost savings, and the ability to diagnose multiple diseases in a single test. Some companies in the Syndromic Multiplex Diagnostic market include Abbott, Bio-Rad, Cepheid, Luminex, and Qiagen. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
